Scholar Rock Holding Corporation Common Stock SRRK
Key Stats
- Today's Range
- $44.09 – $46.41
- 50-Day Range
- $43.23 – $52.19
- 52-Week Range
- $27.07 – $52.19
- Volume
- 1.15 million shs
- Average Volume
- 1.22 million shs
- Market Cap
- $5.29 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 19.18
- Price / Sales
- —
Short Interest
- Short Interest
- 0.11%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-408,726,000
- Net Margin
- —
- Return on Equity
- -148.08%
- Debt-to-Equity
- —
About Scholar Rock Holding Corporation Common Stock
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.